Skip to main content Help with accessibility Skip to main navigation

BISPHOSPHONATES, oral for treating osteoporosis

Last Updated: 27 September 2017

Body System: Endocrine System


The Pan Mersey Area Prescribing Committee recommends the prescribing of ORAL BISPHOSPHONATES (alendronic acid, ibandronic acid and risedronate sodium) for treating osteoporosis in accordance with NICE TA464.